---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-023047"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T17:45:51.542858+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences Q2 net loss narrows to $9.9M; cash $58.7M after $65M private placement

## Summary
- GAAP net loss ($9.9M) vs ($14.0M) YoY; Non-GAAP net loss ($8.5M) vs ($11.9M).
- Cash totaled $58.7M at June 30, 2023, up from $14.8M a year ago; Q2 warrant exercises added $14.6M gross.
- Closed $65M private placement with Executive Chairman Robert Duggan, cancelling all debt owed to him.
- Preclinical: nsPFA cardiac clamp ablates 25mm tissue in 1.25 sec; catheter isolates pulmonary veins in ~5 sec.
- First-in-human study of nsPFA for benign thyroid nodules showed positive safety and tissue response.

## SEC filing metadata
- accession: 0001437749-23-023047
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774923023047/0001437749-23-023047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774923023047/plse20230809_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-023047
- JSON: https://secwatch.observer/filing/0001437749-23-023047.json
- Plain text: https://secwatch.observer/filing/0001437749-23-023047.txt

## Key facts
- Earnings Releases
  PULSE BIOSCIENCES, INC. reported the fiscal quarter ended June 30, 2023 results: net income ($9.9) million.
  - Period: the fiscal quarter ended June 30, 2023
  - Net income: ($9.9) million
  - Result: reported results
  source text: GAAP net loss for the three months ended June 30, 2023 was ($9.9) million compared to ($14.0) million for the three months ended June 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774923023047/0001437749-23-023047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.